Table 1.
Code | Number of Vials Tested | BPG content (%) a (Mean ± SD) | Melting Point b (°C) | Specific surface area (m2/g) | Average particle size; D50 c (µm) | D10‐D90 c (µm) |
---|---|---|---|---|---|---|
1 | 3 | 106.1 ± 0.7 | 126 | 0.94 | 15 | 3‐48 |
2 | 6 | 98.4 ± 2.5 | 124 | 0.55 | 33 | 5‐86 |
3 | 3 | 97.5 ± 0.4 | 124 | 0.48 | 23 | 6‐71 |
4 | 1 | 105.6 | 129 | 0.45 | 25 | 6‐90 |
5 | 3 | 106.4 ± 3.3 | 125 | 0.39 | 32 | 8‐89 |
6 | 3 | 105.8 ± 1.8 | 131 | 0.51 | 22 | 6‐62 |
7 | 6 | 107.0 ± 1.4 | 129 | 0.52 | 37 | 5‐95 |
8 | 6 | 106.6 ± 2.7 | 129 | 0.54 | 22 | 6‐63 |
9 | 6 | 106.3 ± 2.6 | 133 | 0.45 | 27 | 7‐71 |
10 | 3 | 99.0 ± 1.3 | 124 | 1.33 | 8 | 2‐34 |
11 | 6 | 97.2 ± 1.6 | 123 | 0.37 | 33 | 11‐91 |
12 | 3 | 104.6 ± 2.4 | 127 | 0.39 | 30 | 8‐90 |
13 | 1 | 105.3 | 128 | 0.37 | 33 | 8‐99 |
14 | 3 | 106.9 ± 2.1 | 128 | 0.55 | 20 | 6‐55 |
15 | 3 | 106.8 ± 1.8 | 126 | 0.94 | 18 | 3‐50 |
16 | 3 | 106.1 ± 0.8 | 132 | 1.07 | 18 | 2‐59 |
17 | 3 | 103.4 ± 2.5 | 132 | 0.92 | 11 | 3‐34 |
18 | 3 | 98.3 ± 1.1 | 124 | 1.11 | 10 | 3‐34 |
19 | 3 | 98.1 ± 0.4 | 124 | 1.03 | 11 | 3‐35 |
20 | 6 | 98.0 ± 1.0 | 126 | 1.01 | 11 | 3‐36 |
21 | 6 | 91.5 ± 1.1 | 127 | |||
22 | 6 | 97.3 ± 1.2 | 126 | |||
23 | 3 | 100.2 ± 0.4 | 126 | |||
24 | 3 | 101.9 ± 2.4 | 128 | |||
25 | 3 | 101.9 ± 2.4 | 127 | |||
26 d | 3 | 98.5 ± 1.0 | 127 | |||
27 d | 3 | 99.9 ± 3.4 | 128 | |||
28 | 6 | 102.7 ± 5.0 | 127 | |||
29 | 1 | 100.8 | 128 | |||
30 | 6 | 108.1 ± 7.4 | 126 | |||
31 | 6 | 98.5 ± 0.9 | 124 | |||
32 | 1 | 102.6 | 127 | |||
33 | 1 | 101.4 | 129 | |||
34 | 1 | 101.6 | 128 | |||
35 e | 6 | 95.8 ± 5.1 e | 126 |
Pharmacopeial requirements are 90%‐115% BPG content for the injectable suspension in the United States Pharmacopeia and 94.5%‐102% for the active pharmaceutical ingredient (API) in the British Pharmacopoeia. The BPG content in the powder for injection is expressed as percent of the nominal amount, based on the penicillin G concentration and a confirmed 2:1 ratio with benzathine, and should be considered in the context of the assay coefficient of variation (SD/mean) for the measured analyte (penicillin G) being 2.5% and potential systematic errors associated with aliquot measurements.
Reference range of the API is 123‐124° (The Merck Index). Melting point was determined on the BPG powder for injection.
D50 is the 50% point of the particle size distribution and represents the median diameter of the particles in the suspension. D10 and D90 are the 10% and 90% points of the distribution and are used to represent the range of the particle size distribution.
Samples 26 and 27 were the same batch sourced from two different countries
Sample 35 was analyzed three months after the stated expiry date